Consensus Recommendations on Adjunctive Topical Management of Atopic Dermatitis

Area of Science:

• Dermatology
• Immunology
• Genetics

Background:

• Atopic dermatitis (AD) is a prevalent, chronic, relapsing skin condition impacting global populations.
• The disease significantly affects the quality of life for patients and their families.
• Complex pathophysiology leads to varied clinical presentations and severity.

Purpose of the Study:

• To provide a comprehensive overview of atopic dermatitis (AD).
• To discuss the pathophysiology, medical management, and disease course of AD.
• To emphasize adjunctive topical skin barrier approaches for prolonging disease remission.

Main Methods:

• Literature review of AD prevalence, severity, and progression.
• Summaries of AD pathophysiology and current medical treatments.
• Discussion of epidermal barrier dysfunction and skin microbiome alterations in AD.

Main Results:

• AD management requires addressing its complex pathophysiology and chronicity.
• Epidermal barrier dysfunction and altered skin microbiome are key features of AD.
• Adjunctive topical skin barrier therapies show potential for extending remission periods.

Conclusions:

• Effective AD management necessitates a multi-faceted approach.
• Targeting skin barrier repair and microbiome balance may improve long-term outcomes.
• Further research into adjunctive therapies is crucial for optimizing patient care and prolonging remission.